29.04.2015 • NewsDede WillamsEvoniksuperabsorbent polymers

Evonik Inaugurates €1 Million Super Absorbers Center

German chemical producer Evonik has inaugurated a new €1 million application technology center for superabsorbent polymers in Krefeld, Germany.

Evonik said the enlarged laboratory strengthens its position as an innovative solutions provider for superabsorbent polymers, allowing implementation of the newest test methods, which will further strengthen product knowledge and target-oriented innovation efforts.

The new facility is equipped for the evaluation of superabsorbent polymers and hygiene articles, such as the new EDANA mannequin test for incontinence articles.

For the first time, the company said, this test allows the application of realistic in-use conditions to the standardized lab evaluation. It is also open to customers for training and testing sessions.

"Our customers will directly benefit from an even further improved technical service," said Norbert Westerholt, head of Evonik's Baby Care Business Line. The service capabilities of the German company are the industry-wide benchmark and the basis for strong partnerships and development collaborations with its customers, he said.

As one of the leading suppliers of superabsorbent polymers with manufacturing plants in the US, Germany and Saudi Arabia, the Evonik business employs more than 600 people worldwide.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.